scholarly journals A Rare Case of Autosomal Dominant Polycystic Kidney Disease Presenting in utero

2011 ◽  
Vol 3 (1) ◽  
pp. 44-45
Author(s):  
Hema Dhumale ◽  
Yeshita Pujar ◽  
Bhavana Sherigar ◽  
Babasaheb Raosaheb Desai ◽  
Geeta Durdi ◽  
...  

ABSTRACT Autosomal dominant polycystic kidney disease (ADPKD) is the most widespread cause of genetic nephropathy. Only 25% of patients are symptomatic.1 One in 1,000 people carries the autosomal dominant polycystic kidney disease mutant gene. Autosomal dominant polycystic kidney disease is usually asymptomatic until the third or fourth decade of life, although histological evidence of the disease is likely to be present from intrauterine life. Rarely, however, kidneys that are anatomically similar may cause death in infancy or early childhood, and the condition has been designated as “adult variety occurring in infancy”.2 In ADPKD, cysts develop only later in adulthood yet exceptionally cysts may be encountered in utero. We report a rare case of ADPKD, which was diagnosed by ultrasonography in utero as infantile polycystic kidney disease due to the presence of bilateral enlarged hyperechogenic kidneys with oligohydramnios. Pregnancy was terminated and autopsy revealed it to be an adult polycystic kidney disease. This case is reported due to its rare presentation in utero.

2019 ◽  
Vol 54 (S1) ◽  
pp. 165-165
Author(s):  
M. Cal ◽  
I. Godinho ◽  
M. Soeiro e Sá ◽  
M. Cunha ◽  
R. Carvalho

2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Ayşe Şeker Koçkara ◽  
Mansur Kayataş ◽  
Can Huzmeli ◽  
Ferhan Candan ◽  
Cesur Gümüş

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is responsible for 8–10% of patients with end-stage renal failure. The major extrarenal complications of ADPKD are cardiovascular abnormalities. Interrupted aortic arch (IAA) is a lethal congenital cardiac abnormality seen with a frequency of 3/1000000 births and is defined as a segment of the arcus aorta being atresic. In the literature, there are no any reports showing that polycystic kidney disease and interrupted aortic arch occur together. In this study, we present a rare case in which the patient has polycystic kidney disease and IAA together and discuss whether IAA is a complication of ADPKD.


Praxis ◽  
2009 ◽  
Vol 98 (25) ◽  
pp. 1511-1516
Author(s):  
Serra ◽  
Wüthrich

Die autosomal dominante polyzystische Nierenerkrankung (autosomal dominant polycystic kidney disease, ADPKD) ist charakterisiert durch eine massive Vergrösserung beider Nieren, bedingt durch unzählige Zysten. Die Zystenbildung beginnt bereits in utero und das kontinuierliche Zystenwachstum führt zur Kompression und Zerstörung des nicht-zystischen Nierenparenchyms, sodass schliesslich ein Nierenersatz in der 5. bis 6. Lebensdekade notwendig wird. Bisher gab es keine kausale Therapie, welche das Fortschreiten der Krankheiten aufhält. Tierexperimentelle Daten zeigen, dass die medikamentöse Inhibition eines zentralen Regulators der Zellproliferation, dem so genannten «mammalian target of rapamycin» (mTOR), den Kranheitsverlauf der ADPKD verlangsamen kann. Die vorliegende Übersicht vermittelt einen Einblick in die Erkrankung und in die neue therapeutische Möglichkeit des mTOR Inhibitors Sirolimus, welcher zurzeit in klinischen Studien getestet wird.


2019 ◽  
Vol 5 (5) ◽  
pp. e302-e306
Author(s):  
Swayamsidha Mangaraj ◽  
Debasish Patro ◽  
Arun Kumar Choudhury ◽  
Anoj Kumar Baliarsinha

Objective: Acromegaly is a classic endocrine disorder caused by a growth hormone (GH)–secreting pituitary adenoma in an overwhelming majority of patients. The diagnosis may be delayed by several years due to the slow growing and insidious nature of the disease. Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by multiple renal cysts and various other systemic manifestations. The purpose of this article is to report a rare case of acromegaly with coexistent ADPKD. Methods: We report a case of 42-year-old female with acromegaly and ADPKD along with a brief review of literature. Results: The patient was referred to us for evaluation of progressive acral enlargement and coarsening of facial features. Endocrine evaluation confirmed the diagnosis of acromegaly due to an underlying GH–secreting pituitary macroadenoma. She was also found to have ADPKD. We discuss the clinical features and management of the patient. Conclusion: The association of pituitary adenomas and ADPKD is very rare and interesting. All affected individuals with pituitary adenomas and ADPKD in the literature are women. Furthermore, all reported pituitary adenomas in these individuals (including ours) are functional GH–secreting ones. These findings argue against a mere chance association between the two diseases.


2018 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
KrishanL Gupta ◽  
Jasmine Sethi ◽  
Raja Ramachandran ◽  
Vivek Kumar ◽  
Manish Rathi ◽  
...  

2020 ◽  
Vol 49 (1) ◽  
pp. 512-512
Author(s):  
Salem Gaballa ◽  
Kyaw Hlaing ◽  
Brijesh Patel ◽  
Ameenjamal Ahmed ◽  
Safa Moursy ◽  
...  

2016 ◽  
Vol 87 (8) ◽  
pp. 605-608
Author(s):  
Magdalena Nowak ◽  
Hubert Huras ◽  
Marcin Wiecheć ◽  
Robert Jach ◽  
Małgorzata Radoń-Pokracka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document